REGENXBIO Inc. (RGNX)

NasdaqGS • Currently down 0.26 (-2.83%) in today's trading session

1 member of Congress has disclosed 4 trades in REGENXBIO Inc. (RGNX) via STOCK Act filings. The most recent disclosure was a sale by Peter Welch on 8 November 2019. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

REGENXBIO Inc. is currently trading at $8.94, positioned at 32% of its 52-week range ($5.46 – $16.19).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$8.94
24h Change
-0.26 (-2.83%)
52 Week Range
$5.46–$16.19
View on NASDAQ

REGENXBIO Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for RGNX

Select to highlight on chart
4 transactions
Compliance: 50%
Peter Welch8 Nov 201914 Nov 2019SaleStock$1,001 - $15,000N/A
Peter Welch8 Nov 201912 Aug 2020SaleStock$1,001 - $15,000N/A
Peter Welch22 Oct 201914 Nov 2019PurchaseStock$1,001 - $15,000N/A
Peter Welch22 Oct 201912 Aug 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

No overview data available for this stock

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$-1.21

Rev. Est.

$15.9M

Days Until

59

Recent Quarters

Q2 20266 Aug
EPS$0.43
Beat 446.2%
Q1 202614 May
EPS$-1.72
Miss 26.5%
Q4 20255 Mar
EPS$-1.30
Miss 28.7%
Q3 20256 Nov
EPS$-1.20
Beat 13.0%
Q2 20257 Aug
EPS$-1.38
Miss 22.1%
Q1 202512 May
EPS$0.12
Miss 70.7%
Q4 202413 Mar
EPS$-1.01
Beat 20.5%
Q3 20246 Nov
EPS$-1.17
Miss 0.9%
Q2 20241 Aug
EPS$-1.05
Beat 18.6%
Q1 20248 May
EPS$-1.38
Miss 7.8%
Q4 202327 Feb
EPS$-1.43
Miss 12.6%
Q3 20238 Nov
EPS$-1.41
Beat 2.1%
Q2 20232 Aug
EPS$-1.66
Miss 31.8%
Q1 20233 May
EPS$-1.53
Miss 0.7%
Q4 202228 Feb
EPS$-1.38
Beat 6.8%
Q3 20223 Nov
EPS$-1.75
Miss 12.9%
Q2 20223 Aug
EPS$-1.58
Miss 9.7%
Q1 20224 May
EPS$-1.62
Miss 25.6%
Q4 20211 Mar
EPS$6.67
Beat 41.6%
Q3 20212 Nov
EPS$-1.37
Miss 57.5%
Q2 20219 Aug
EPS$-1.36
Miss 25.9%
Q1 20215 May
EPS$-1.20
Miss 6.2%
Q4 20201 Mar
EPS$-1.24
Miss 211.7%
Q3 20204 Nov
EPS$0.23
Beat 125.8%
Q2 20206 Aug
EPS$-0.91
Miss 2.3%
Q1 20207 May
EPS$-1.08
Miss 24.1%
Q4 201926 Feb
EPS$-0.72
Miss 80.0%
Q3 20195 Nov
EPS$-0.94
Miss 3.3%
Q2 20197 Aug
EPS$-0.72
Miss 44.0%
Q1 20197 May
EPS$-0.89
Miss 4.7%
Q4 201827 Feb
EPS$0.04
Beat 112.5%
Q3 20187 Nov
EPS$-0.56
Beat 34.9%
Q2 20188 Aug
EPS$0.15
Miss 92.1%
Q1 20188 May
EPS$3.04
Beat 204.0%
Q4 20176 Mar
EPS$-0.51
Beat 28.2%
Q3 20178 Nov
EPS$-0.67
Beat 5.6%
Q2 20178 Aug
EPS$-0.47
Beat 42.0%
Q1 20179 May
EPS$-0.82
Miss 6.5%
Q4 20167 Mar
EPS$-0.74
Miss 23.3%
Q3 20169 Nov
EPS$-0.69
Miss 15.0%
Q2 20169 Aug
EPS$-0.55
Miss 5.8%
Q1 20165 May
EPS$-0.41
Beat 8.9%
Q4 20153 Mar
EPS$-0.20
Beat 39.4%
Q3 20155 Nov
EPS$-1.52
Q2 201517 Sept
EPS$-0.30
Q1 201530 Jun
EPS$-0.26
Q3 201431 Dec
EPS$-0.18
Q2 201430 Sept
EPS$-0.14
Q1 201430 Jun
EPS$-0.21
Q4 201331 Mar
EPS$0.08

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about RGNX

Which members of Congress have traded RGNX?
1 member of Congress has disclosed 4 trade in REGENXBIO Inc. (RGNX) under the STOCK Act: Peter Welch.
When was RGNX most recently disclosed by Congress?
The most recent RGNX disclosure was a sale by Peter Welch on 8 November 2019.
What is the total disclosed congressional trading volume for RGNX?
Members of Congress have disclosed approximately $16K in RGNX purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in RGNX?
This RGNX page updates as soon as new STOCK Act disclosures are filed for REGENXBIO Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.